Arterial hypertension and sleep apnoea syndrome (review)

Czech version

Authors: Genzor S. ¹; Kolek V. ¹; Václavík J. ²
Authors‘ workplace: Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc 2 I. interní klinika – kardiologická LF UP a FN Olomouc ¹
Published in: Kardiol Rev Int Med 2018, 20(4): 304-306

Overview

Sleep apnoea syndrome is the most common sleep-related breathing disorder. Its comorbidities may reduce not only the quality of life but the life expectancy of the patients as well. The association of sleep apnoea syndrome with cardiovascular diseases has been confirmed repeatedly. In the review, we summarize the main pathophysiological mechanisms leading to the higher incidence of arterial hypertension in sleep apnoea patients, the clinical consequences of the relationship between sleep apnoea and arterial hypertension, and the implications in therapy. The therapy of sleep apnoea patients has to be comprehensive; an appropriate treatment may lower the elevated blood pressure and the overall cardiovascular risk.

Key words:

sleep apnoea – arterial hypertension – cardiovascular risk – CPAP

Sources

1. International classification of sleep disorders. (3rd ed). Darien, IL USA: American Academy of Sleep Medicine 2014.

2. Javaheri S. Sleep-related breathing disorders in heart failure. In: Mann DL (ed.) Heart failure: a companion to braunwald's heart disease. Saunders: Philadelphia, PA, USA, 2003, 478.

3. Klozar J, Plzák J, Ondrová M et al. Doporučený postup u dospělých pacientů s poruchami dýchání ve spánku. Česká společnost pro výzkum spánku a spánkovou medicínu, 2016. Dostupné na: http:/ / www.sleep-society.cz/ images/ odborne/ doporucene-postupy/ Guidelines-2016-def-13.9.pdf.

4. Kamasova M, Vaclavik J, Vaclavik T et al. Ambulatory screening for obstructive sleep apnea in patients with resistant arterial hypertension. Sleep Breath 2018; 22(2): 361– 367. doi: 10.1007/ s11325-017-1583-5.

5. Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 2011; 123(16): 1737– 1744. doi: 10.1161/ CIRCULATIONAHA.110.005645.

6. Viera AJ. Hypertension update: current guidelines. FP Essent 2018; 469: 11– 15.

7. Meng F, Ma J, Wang W et al. Obstructive sleep apnea syndrome is a risk factor of hypertension. Minerva Med 2016; 107(5): 294– 299.

8. Wang S, Niu X, Zang P et al. Analysis of OSAS incidence and influential factors in middle-aged and elderly patients with hypertension. Minerva Med 2018. doi: 10.23736/ S0026-4806.18.05635-5.

9. Xia W, Huang Y, Peng B et al. Relationship between obstructive sleep apnoea syndrome and essential hypertension: a dose-response meta-analysis. Sleep Med 2018; 47: 11– 18. doi: 10.1016/ j.sleep.2018.03.016.

10. Hou H, Zhao Y, Yu W et al. Association of obstructive sleep apnea with hypertension: A systematic review and meta-analysis. J Glob Health 2018; 8(1): 010405. doi: 10.7189/ jogh.08.010405.

11. Zhang W, Si LY. Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and possible therapeutic approaches. Ups J Med Sci 2012; 117(4): 370– 382. doi: 10.3109/ 03009734.2012.707253.

12. McEvoy RD, Antic NA, Heeley E, Luo Y al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016; 375(10): 919– 931. doi: 10.1056/ NEJMoa1606599.

13. Walia HK, Griffith, SD, Foldvary-Schaefer N et al. Longitudinal effect of CPAP on BP in resistant and nonresistant hypertension in a large clinic-based cohort. Chest 2016; 149(3): 747– 755. doi: 10.1378/ chest.15-0697.

14. Sova M, Sovova E, Hobzova M et al. The effect of continuous positive airway pressure therapy on the prevalence of masked hypertension in obstructive sleep apnea patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159(2): 277– 282. doi: 10.5507/ bp.2014.063.

15. Martínez-García MA, Capote F, Campos-Rodríguez F et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension The HIPARCO randomized clinical trial. JAMA 2013; 310(22): 2407– 2415. doi: 10.1001/ jama.2013.281250.

16. Chirinos JA, Gurubhagavatula I, Teff K et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 2014; 370(24): 2265– 2275. doi: 10.1056/ NEJMoa1306187.

17. Lysdahl M, Haraldsson PO. Long-term survival after uvulopalatopharyngoplasty in nonobese heavy snorers: a 5- to 9 - year follow-up of 400 consecutive patients. Arch Otolaryngol Head Neck Surg 2000; 126(9): 1136– 1140.

18. Iftikhar IH, Hays ER, Iverson MA et al. Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 2013; 9(2): 165– 174. doi: 10.5664/ jcsm.2420.